샘플 요청 목록

 카트 문의
시장보고서
상품코드
1886340

프로테인 A 수지 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품 유형, 매트릭스 유형, 용도별(면역침강, 항체 정제), 최종사용자별, 지역별, 경쟁별 세분화(2020-2030년)

Protein A Resin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Matrix Type, By Application (Immunoprecipitation, Antibody Purification), By End User, By Region, and By Competition, 2020-2030F
발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 186 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 프로테인 A 수지 시장은 2024년에 13억 8,000만 달러로 평가되며, 2030년까지 CAGR 10.04%로 성장하며, 24억 5,000만 달러에 달할 것으로 예측됩니다. 단백질 A 수지는 주로 항체, 특히 면역글로불린 G의 정제에 사용되는 친 화성 크로마토그래피 매체로, 복잡한 생물학적 혼합물에서 Fc 영역에 대한 특이적 결합을 통해 분리합니다. 시장 확대는 만성질환 치료에 대한 세계 수요 증가와 바이오의약품 연구개발에 대한 투자 증가가 주요 요인으로 작용하고 있습니다.

시장 개요
예측 기간 2026-2030
시장 규모 : 2024년 13억 8,000만 달러
시장 규모 : 2030년 24억 5,000만 달러
CAGR : 2025-2030년 10.04%
가장 빠르게 성장하는 부문 천연 단백질 A
최대 시장 북미

주요 시장 성장 촉진요인

모노클로널 항체 및 생물제제에 대한 수요 증가는 단백질 A 수지 시장을 크게 견인하고 있습니다. 이러한 치료제는 엄격한 품질 및 규제 가이드라인을 충족하기 위해 고효율 정제 방법이 필요하기 때문입니다. 치료 용도의 확대와 이러한 의약품의 세계적인 보급은 첨단 다운스트림 공정 처리를 직접적으로 필요로 하고 있습니다.

주요 시장 과제

단백질 A 수지에 내재된 높은 비용은 세계 단백질 A 수지 시장의 확대를 크게 저해하고 있습니다. 이러한 막대한 지출은 특히 예산이 한정된 중소규모의 기업이나 신생 바이오제약 기업에게 큰 장벽이 되고 있습니다.

주요 시장 동향

고용량 및 알칼리 안정성을 가진 수지의 개발은 바이오의약품 제조업체의 정제 효율을 직접적으로 향상시키고 운영 비용을 절감할 수 있다는 점에서 전 세계 단백질 A 수지 시장의 중요한 추세입니다. 이러한 첨단 수지는 더 짧은 시간에 더 많은 양의 바이오의약품을 처리할 수 있게 해줍니다. 이는 항체치료제에 대한 수요가 증가하고 있다는 점을 고려할 때 매우 중요합니다.

자주 묻는 질문

  • 2024년과 2030년의 프로테인 A 수지 시장 규모는 어떻게 되나요?
  • 프로테인 A 수지 시장의 주요 성장 촉진 요인은 무엇인가요?
  • 프로테인 A 수지 시장의 주요 과제는 무엇인가요?
  • 프로테인 A 수지 시장의 주요 동향은 무엇인가요?
  • 프로테인 A 수지 시장에서 가장 빠르게 성장하는 부문은 무엇인가요?
  • 프로테인 A 수지 시장의 최대 시장은 어디인가요?

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 프로테인 A 수지 시장 전망

  • 시장 규모·예측
    • 금액별
  • 시장 점유율·예측
    • 제품별(천연 프로테인 A, 재조합 프로테인 A)
    • 매트릭스 유형별(아가로스 기반, 유리 또는 실리카 기반, 유기 폴리머 기반)
    • 용도별(면역침강(IP), 항체 정제)
    • 최종사용자별(바이오의약품 제조업체, 임상 연구소, 학술기관)
    • 지역별
    • 기업별(2024)
  • 시장 맵

제6장 북미의 프로테인 A 수지 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 프로테인 A 수지 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 유럽 : 국가별 분석
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인

제8장 아시아태평양의 프로테인 A 수지 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 중동 및 아프리카의 프로테인 A 수지 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 중동 및 아프리카 : 국가별 분석
    • 사우디아라비아
    • 아랍에미리트
    • 남아프리카공화국

제10장 남미의 프로테인 A 수지 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 남미 : 국가별 분석
    • 브라질
    • 콜롬비아
    • 아르헨티나

제11장 시장 역학

  • 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 합병·인수
  • 제품 출시
  • 최근 동향

제13장 세계의 프로테인 A 수지 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

  • 업계내 경쟁
  • 신규 참여의 가능성
  • 공급업체의 힘
  • 고객의 힘
  • 대체품의 위협

제15장 경쟁 구도

  • GE Healthcare Inc.
  • Merck Millipore(Merck KGaA)
  • PerkinElmer, Inc.
  • GenScript Biotech Corp.
  • Agilent Technologies, Inc.
  • Repligen Corp.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Abcam PLC.
  • Novasep Holdings SAS

제16장 전략적 제안

제17장 조사회사 소개·면책사항

KSA 25.12.19

The Global Protein A Resin Market, valued at USD 1.38 Billion in 2024, is projected to experience a CAGR of 10.04% to reach USD 2.45 Billion by 2030. Protein A resin is an affinity chromatography medium primarily used for the purification of antibodies, especially immunoglobulin G, from complex biological mixtures through specific binding to the Fc region. The market's expansion is fundamentally driven by the escalating global demand for monoclonal antibody therapeutics, particularly in treating chronic diseases, and increasing investments in biopharmaceutical research and development.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.38 Billion
Market Size 2030USD 2.45 Billion
CAGR 2025-203010.04%
Fastest Growing SegmentNatural Protein A
Largest MarketNorth America

Key Market Drivers

The increasing demand for monoclonal antibodies and biologics significantly drives the Protein A resin market, as these therapeutics require highly efficient purification methods to meet stringent quality and regulatory guidelines. The expanding therapeutic applications and global adoption of these medicines directly necessitate advanced downstream processing.

Key Market Challenges

The inherently high cost associated with Protein A resins significantly impedes the expansion of the Global Protein A Resin Market. This substantial expenditure acts as a considerable adoption barrier, particularly for smaller entities and emerging biopharmaceutical companies operating with constrained budgets. Such financial pressure compels some manufacturers to explore less efficient, yet more affordable, alternative purification strategies. This decision often compromises the overall yield and purity achievable, thereby directly impacting the quality and cost-effectiveness of the final biologic product.

Key Market Trends

The development of high-capacity and alkali-stable resins represents a significant trend in the Global Protein A Resin Market by directly enhancing purification efficiency and reducing operational costs for biopharmaceutical manufacturers. These advanced resins enable the processing of larger quantities of biologics within shorter timeframes, which is crucial given the increasing demand for antibody therapeutics.

Key Market Players

  • GE Healthcare Inc.
  • Merck Millipore (Merck KGaA)
  • PerkinElmer, Inc.
  • GenScript Biotech Corp.
  • Agilent Technologies, Inc.
  • Repligen Corp.
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • Abcam PLC.
  • Novasep Holdings SAS

Report Scope:

In this report, the Global Protein A Resin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein A Resin Market, By Product:

  • Natural Protein A
  • Recombinant Protein A

Protein A Resin Market, By Matrix Type:

  • Agarose-based
  • Glass or Silica Based
  • Organic Polymer Based

Protein A Resin Market, By Application:

  • Immunoprecipitation (IP)
  • Antibody Purification

Protein A Resin Market, By End User:

  • Biopharmaceutical Manufacturers
  • Clinical Research Laboratories
  • Academic Institutes

Protein A Resin Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Protein A Resin Market.

Available Customizations:

Global Protein A Resin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein A Resin Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Natural Protein A, Recombinant Protein A)
    • 5.2.2. By Matrix Type (Agarose-based, Glass or Silica Based, Organic Polymer Based)
    • 5.2.3. By Application (Immunoprecipitation (IP), Antibody Purification)
    • 5.2.4. By End User (Biopharmaceutical Manufacturers, Clinical Research Laboratories, Academic Institutes)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Protein A Resin Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Matrix Type
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Protein A Resin Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Matrix Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Protein A Resin Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Matrix Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Protein A Resin Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Matrix Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Protein A Resin Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Matrix Type
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Protein A Resin Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Matrix Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Protein A Resin Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Matrix Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Protein A Resin Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Matrix Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Protein A Resin Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Matrix Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Protein A Resin Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Matrix Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Protein A Resin Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Matrix Type
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Protein A Resin Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Matrix Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Protein A Resin Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Matrix Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Protein A Resin Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Matrix Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Protein A Resin Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Matrix Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Protein A Resin Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Matrix Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Protein A Resin Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Matrix Type
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Protein A Resin Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Matrix Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Protein A Resin Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Matrix Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Protein A Resin Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Matrix Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Protein A Resin Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Matrix Type
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Protein A Resin Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Matrix Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Protein A Resin Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Matrix Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Protein A Resin Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Matrix Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Protein A Resin Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. GE Healthcare Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Merck Millipore (Merck KGaA)
  • 15.3. PerkinElmer, Inc.
  • 15.4. GenScript Biotech Corp.
  • 15.5. Agilent Technologies, Inc.
  • 15.6. Repligen Corp.
  • 15.7. Thermo Fisher Scientific Inc.
  • 15.8. Bio-Rad Laboratories, Inc.
  • 15.9. Abcam PLC.
  • 15.10. Novasep Holdings SAS

16. Strategic Recommendations

17. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제